KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Free Cash Flow (2016 - 2025)

Elevance Health (ELV) has disclosed Free Cash Flow for 17 consecutive years, with -$209.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Free Cash Flow fell 154.43% to -$209.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.2 billion, a 30.27% decrease, with the full-year FY2025 number at $3.2 billion, down 30.27% from a year prior.
  • Free Cash Flow was -$209.0 million for Q4 2025 at Elevance Health, down from $775.0 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $6.2 billion in Q1 2023 to a low of -$3.3 billion in Q4 2023.
  • A 5-year average of $1.5 billion and a median of $1.6 billion in 2023 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: tumbled 236.34% in 2022, then skyrocketed 1341.13% in 2025.
  • Elevance Health's Free Cash Flow stood at $1.3 billion in 2021, then crashed by 236.34% to -$1.8 billion in 2022, then crashed by 81.55% to -$3.3 billion in 2023, then skyrocketed by 111.65% to $384.0 million in 2024, then tumbled by 154.43% to -$209.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Free Cash Flow are -$209.0 million (Q4 2025), $775.0 million (Q3 2025), and $1.8 billion (Q2 2025).